Shepherd Kaplan Krochuk’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-4,300	Closed	-$48K	–	579
2014 Q3	$48K	Sell	4,300 -500	-10%	-$6.36K	0.01%	529
2014 Q2	$88K	Sell	4,800 -900	-16%	-$11.7K	0.01%	515
2014 Q1	$85K	Buy	+5,700	New	+$102K	0.01%	541

Other funds holding AVEO

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DVC

Deer VI & Co Larchmont, New York $2.23M AUM 9.32% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Greylock XI Cambridge, Massachusetts $7.71M AUM 28.23% 1-Year Est. Return

Shepherd Kaplan Krochuk's AVEO Position: Q4 2014 in Review

Shepherd Kaplan Krochuk sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2014, closing a stake of 4,300 shares — an estimated $48K sold.

Shepherd Kaplan Krochuk first reported a position in AVEO in Q1 2014 and held it in 3 quarters. The position peaked at $88K in Q2 2014. 51 funds tracked by Wall St. Rank hold AVEO as of Q4 2014.

Shepherd Kaplan Krochuk reported no remaining AVEO Pharmaceuticals, Inc. position as of Q4 2014 after selling out during the quarter.
Shepherd Kaplan Krochuk sold 4,300 AVEO Pharmaceuticals, Inc. shares in Q4 2014, an estimated $48K.
Shepherd Kaplan Krochuk first reported a position in AVEO Pharmaceuticals, Inc. in Q1 2014 and held it in 3 quarters.
Shepherd Kaplan Krochuk's AVEO Pharmaceuticals, Inc. position peaked at $88K in Q2 2014.
51 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2014.

Based on Shepherd Kaplan Krochuk's 13F filing for Q4 2014, filed 17 Feb 2015.